Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Industry Must Make United Response To NDI Guidance – AHPA

This article was originally published in The Tan Sheet

Executive Summary

A united response from industry on the new dietary ingredient draft guidance could help prevent FDA from creating an even more burdensome policy, say representatives of the American Herbal Products Association.

You may also be interested in...



Supplement Trade Groups A “Unified Choir,” Leaders Say

Supplement trade groups discuss the strengths and strategies of multiple voices representing the industry.

Supplement Trade Groups A “Unified Choir,” Leaders Say

Supplement trade groups discuss the strengths and strategies of multiple voices representing the industry.

Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel